{"id":"W2895716286","doi":"10.1186/s12885-018-4859-7","title":"Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5","year":2018,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"Positive Living North; University of Northern British Columbia; Kelowna General Hospital; University of British Columbia","funders":"Michael Smith Health Research BC","keywords":"SABR volatility model; Medicine; Population; Radiation therapy; Oncology; Randomized controlled trial; Toxicity; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004377049,0.001656241,0.001577515,0.0004164091,0.000553434,0.001017298,0.0008248452,0.001651395,0.007731561],"category_scores_gemma":[0.003394257,0.0004377546,0.001900785,0.0004380594,0.001015555,0.0007124297,0.0005510111,0.002712393,0.00135507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00101026,"about_ca_system_score_gemma":0.002550016,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001153407,"about_ca_topic_score_gemma":0.002024849,"domain_scores_codex":[0.9987854,0.0008047173,0.00005630702,0.000146622,0.00008504986,0.0001219374],"domain_scores_gemma":[0.9980331,0.0004163911,0.0004710167,0.0002602855,0.0002252575,0.0005939612],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9431424,0.02228162,0.003484952,0.0006886121,0.00260582,0.0000739738,0.0001413892,0.000901084,0.003040702,0.0003104631,0.002242584,0.02108646],"study_design_scores_gemma":[0.8465465,0.146229,0.003904706,0.00003726135,0.0007389979,0.00006755244,0.0000337735,0.0004200581,0.0004857773,0.0003137277,0.001208969,0.00001362887],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9741599,0.002576353,0.001869738,0.001506935,0.0004730526,0.01273872,0.002483602,0.0002041709,0.003987567],"genre_scores_gemma":[0.9754591,0.001219987,0.003053203,0.001505864,0.0002978341,0.01127757,0.00309968,0.00002700709,0.004059745],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007731561,"threshold_uncertainty_score":0.02586466,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1169909928118189,"score_gpt":0.3840573739175508,"score_spread":0.2670663811057319,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}